Dr Galsky is a medical oncologist with a clinical and research focus on genitourinary malignancies (bladder, prostate, kidney, and testicular cancers). He obtained his MD from Tufts University School of Medicine. He completed a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center and subsequently joined the faculty at MSKCC. In 2010, he was recruited to Mount Sinai School of Medicine/Tisch Cancer Institute where he currently serves as Professor of Medicine and Director of Genitourinary Medical Oncology, Co-Director of the Center of Excellence for Bladder Cancer, Associate Director for Translational Research, and Co-Leader of the Cancer Clinical Investigation Program.
Dr Galsky’s research has focused on the clinical development of novel therapies for bladder cancer, dissecting the clinical basis for heterogeneity in patient outcomes, and understanding the disconnect between the efficacy and effectiveness of available treatments. His current research extends these efforts to team science-based approaches to dissect the mechanisms underlying response and resistance to treatment strategies in bladder cancer with a focus on immunotherapeutic approaches. He has published many articles based on his research in peer-reviewed publications.
EM-99000 - Date of preparation: May 2022